Cyrona Cell Podcast: Stem Cell Therapy in Malaysia

New Parkinson’s Cell Therapy Research: What Patients Should Know

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 1:56

In this episode, we break down the latest Parkinson’s cell therapy research and what it could mean for patients and families living with Parkinson’s disease.

You’ll learn:

  • What TFG-001 is and how this 3D neural microtissue therapy works
  • Why dopamine-producing neurons are important in Parkinson’s disease
  • How stem cell therapy aims to replace damaged brain cells
  • What researchers discovered in recent preclinical studies
  • Why cell survival, integration, and safety remain major challenges
  • The difference between preclinical research and approved treatments
  • Why patients should be cautious about unapproved stem cell clinics
  • What questions to ask a Parkinson’s specialist about clinical trials and treatment options
  • How therapies using stem cell-derived dopamine neurons could shape future Parkinson’s care

This episode also explains why promising research still takes years of testing before becoming a standard treatment option. While TFG-001 showed encouraging early results in preclinical models, no approved stem cell therapy for Parkinson’s exists today.

If you or a loved one is following advances in Parkinson’s treatment, this episode will help you better understand the science, the risks, and the timeline behind emerging cell therapies.

Blog Link: New Parkinson’s Cell Therapy Research: What Patients Should Know